401795-87-7

Upstream product

• 401795-61-7 2-{2-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-6-methyl-benzoylamino}-3-(4-nitro-phenyl)-propionic acid methyl ester 
• 401795-68-4 (S)-2-[2-(3-Iodo-propyl)-6-methyl-benzoylamino]-3-(4-nitro-phenyl)-propionic acid methyl ester 
• 401795-75-3 2-(9-methyl-1-oxo-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl)-3-(4-nitro-phenyl)-propionic acid methyl ester 
• 401795-29-7 trifluoro-methanesulfonic acid 2-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-6-methyl-phenyl ester 
• 401795-49-1 2-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-6-methyl-benzoic acid 
• 401795-35-5 2-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-6-methyl-benzoic acid methyl ester 
• 401795-42-4 2-(3-hydroxy-propyl)-6-methyl-benzoic acid 
• 1807-43-8 2-(3-hydroxypropyl)-6-methylphenol 
• 3354-58-3 2-allyl-6-methylphenol 
• 4659-45-4 2,6-Dichlorobenzoyl chloride 
• 401795-81-1 3-(4-amino-phenyl)-2-(9-methyl-1-oxo-1,3,4,5-tetrahydro-benzo[c]azepin-2-yl)-propionic acid methyl ester 

Relevant academic research and scientific papers

Synthesis of constrained L-phenylalanine derivatives incorporating a benzazepinone or an azepinone ring as VCAM/VLA-4 antagonists

Novel constrained L-phenylalanine derivatives incorporating a benzazepinone or an azepinone ring were synthesized in 13 and 8 steps, respectively, employing a key base-catalyzed intramolecular cyclization reaction. The product, 2, was comparable in potenc